These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2714068)

  • 1. Successful treatment of progressive disseminated histoplasmosis with amphotericin B methyl ester.
    Neihart RE; Hinthorn DR; Hoeprich PD; Liu C
    Diagn Microbiol Infect Dis; 1989; 12(1):17-9. PubMed ID: 2714068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo comparisons of amphotericin B and N-D-ornithyl amphotericin B methyl ester.
    Kobayashi GS; Little JR; Medoff G
    Antimicrob Agents Chemother; 1985 Mar; 27(3):302-5. PubMed ID: 3994345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conditions associated with relapse of amphotericin B-treated disseminated histoplasmosis.
    Bradsher RW; Alford RH; Hawkins SS; Spickard WA
    Johns Hopkins Med J; 1982 Apr; 150(4):127-31. PubMed ID: 6278196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative chemotherapeutic activity of amphotericin B and amphotericine B methy ester.
    Bonner DP; Tewari RP; Solotorovsky M; Mechlinski W; Schaffner CP
    Antimicrob Agents Chemother; 1975 Jun; 7(6):724-9. PubMed ID: 1155916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liposomal amphotericin B-induced reversible ototoxicity in a patient with disseminated histoplasmosis.
    Ramu R; Sharma B; Karunakara D; Paliwal P; Bansal N; Taneja RS
    Indian J Pharmacol; 2021; 53(2):157-159. PubMed ID: 34100400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of histoplasmosis.
    Kauffman CA
    Expert Opin Pharmacother; 2002 Aug; 3(8):1067-72. PubMed ID: 12150686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liposomal amphotericin B therapy of murine histoplasmosis.
    Graybill JR; Bocanegra R
    Antimicrob Agents Chemother; 1995 Aug; 39(8):1885-7. PubMed ID: 7486941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. African histoplasmosis: report of two patients treated with amphotericin B and ketoconazole.
    Akpuaka FC; Gugnani HC; Iregbulam LM
    Mycoses; 1998 Nov; 41(9-10):363-4. PubMed ID: 9916457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histoplasmosis--a ten year follow-up.
    Johnston AW; Brown PA; Ewen SW
    J Infect; 1996 Sep; 33(2):111-3. PubMed ID: 8889998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liposomal amphotericin B-induced hypotension leading to ST segment elevated myocardial infarction.
    Golwala H; Patel N; Zacharias S; Lozano P
    Am J Ther; 2011 Sep; 18(5):e157-8. PubMed ID: 21734533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overview of histoplasmosis.
    Kurowski R; Ostapchuk M
    Am Fam Physician; 2002 Dec; 66(12):2247-52. PubMed ID: 12507161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disseminated histoplasmosis in a patient after orthotopic liver transplantation.
    Vinayek R; Balan V; Pinna A; Linden PK; Kusne S
    Clin Transplant; 1998 Jun; 12(3):274-7. PubMed ID: 9642523
    [No Abstract]   [Full Text] [Related]  

  • 13. Cerebral histoplasmosis in the azole era: report of four cases and review.
    Saccente M; McDonnell RW; Baddour LM; Mathis MJ; Bradsher RW
    South Med J; 2003 Apr; 96(4):410-6. PubMed ID: 12916564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disseminated histoplasmosis successfully treated with liposomal amphotericin B following azathioprine therapy in a patient from a nonendemic area.
    Poveda F; García-Alegría J; de las Nieves MA; Villar E; Montiel N; del Arco A
    Eur J Clin Microbiol Infect Dis; 1998 May; 17(5):357-9. PubMed ID: 9721967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antifungal therapy for central nervous system histoplasmosis, using a newly developed intracranial model of infection.
    Haynes RR; Connolly PA; Durkin MM; LeMonte AM; Smedema ML; Brizendine E; Wheat LJ
    J Infect Dis; 2002 Jun; 185(12):1830-2. PubMed ID: 12085335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disseminated histoplasmosis with oral manifestation.
    Epifanio RN; Brannon RB; Muzyka BC
    Spec Care Dentist; 2007; 27(6):236-9. PubMed ID: 18683806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of relapse of histoplasmosis with itraconazole in patients with the acquired immunodeficiency syndrome.
    Wheat J; Hafner R; Wulfsohn M; Spencer P; Squires K; Powderly W; Wong B; Rinaldi M; Saag M; Hamill R; Murphy R; Connolly-Stringfield P; Briggs N; Owens S;
    Ann Intern Med; 1993 Apr; 118(8):610-6. PubMed ID: 8383934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disseminated histoplasmosis presenting as diabetic keto-acidosis in an immunocompetent patient.
    Niknam N; Malhotra P; Kim A; Koenig S
    BMJ Case Rep; 2017 Jan; 2017():. PubMed ID: 28062431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined therapy with amphotericin B and caspofungin in an experimental model of disseminated histoplasmosis.
    Rodríguez-Arellanes G; Taylor ML; Pérez-Torres A; Curiel-Quesada E; Vargas-Mendoza CF; Martínez-Rivera MA
    Rev Invest Clin; 2009; 61(1):4-10. PubMed ID: 19507469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disseminated histoplasmosis of infancy in one of the twins.
    Quilter LA; Kleiman MB; Kirsch E; Wheat LJ
    Pediatr Infect Dis J; 2012 Sep; 31(9):990-1. PubMed ID: 22572753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.